Dendritic cells (DCs) and airway epithelial cells (AECs) are in close proximity, and AECs secrete factors such as retinoic acid which induce tolerance in DCs at homeostasis. However, the question remains as to how DCs in the lung are able to respond to pathogens in the immunosuppressive environment. Using an in vitro human myeloid DC (mDC)-AEC co-culture system, we demonstrate that AECs induced several gene changes in the mDCs cultured with AECs compared to the mDCs not cultured with AECs. Analysis revealed that several chemokine genes were altered. These chemokine genes could serve to attract neutrophils, natural killer (NK) T as well as T helper type 1 (Th1)/Th2 cells to the airways. Genes priming lipid and major histocompatibility complex (MHC) class II antigen presentation were also up-regulated, along with certain anti-microbial protein genes. In addition, the expression and function of pathogen-sensing Toll-like receptors (TLRs) as well as Nod-like receptors (NLRs) and their downstream signalling molecules were up-regulated in mDCs cultured with AECs. Moreover, murine mucosal DCs from the lung expressed significantly higher levels of TLRs and NLRs compared to peripheral DCs from the spleen. These results indicate that AECs prime mDCs to enhance their immunogenicity, which could be one of the mechanisms that compensates for the immunosuppressive mucosal environment.
Introduction
The respiratory tract represents a significant portal of entry for many pathogens that cause significant morbidity and mortality [1] . A series of structural and functional barriers protect the respiratory system against harmful and innocuous particulate material [2] [3] [4] [5] . It includes the surfactant film [2] , the airway epithelial cells (AECs) [3, 4] and dendritic cells (DCs) [3] . DCs are the primary responders to a threat and play a critical role in limiting inflammation to self and harmless antigens in the periphery and in the mucosa. DCs in the respiratory mucosa are situated in the basolateral space, separated from the inhaled air only by the epithelium tight-junction barrier [6, 7] . Lung mucosal microenvironment influences DCs to adopt an inhibitory phenotype which raises the threshold of activation to prevent response against harmless antigens and pathogens [5, 8] . This is extremely important in preventing inflammation and maintaining lung homeostasis, as increased sterile inflammation in the lung is a major risk factor for asthma, chronic obstructive pulmonary disease (COPD) and infections.
As DCs exist in close proximity to AECs, both cells influence the functions of each other. For example, during infection, proinflammatory cytokine secretion by DCs not only increases the permeability of the epithelial cell barrier to allow infiltration of other immune cells, but also upregulates the expression anti-microbial peptides in AECs [9] . Furthermore, we have demonstrated previously that DCs from elderly individuals produce spontaneously high levels of damaging proinflammatory mediators which promote the secretion of various chemokines from AECs, resulting in enhanced airway inflammation [10] . As DCs influence epithelial cells, so do AECs impact DC functions [11] . Maintenance of immune homeostasis under steady-state conditions within the airway tract is a dynamic process involving a high turnover of airway DCs [12] . An array of regulatory mediators that are expressed constitutively or induced by AECs are known to help maintain local immune homeostasis within the airway mucosal microenvironment [13] . The abundance of immunosuppressive factors such as the vitamin A metabolite, retinoic acid (RA) and transforming growth factor (TGF)-b secreted by AECs are critical for preventing inflammation to harmless antigens at homeostasis [8, [14] [15] [16] . AECs lying in close proximity are constantly engaged in cross-talk with monocytic precursor cells and modulate the functional phenotype of fully differentiated DCs to induce an efficient defence reaction in the presence of inflammatory stimuli [17] . During inflammation a marked increase in DC population, accompanied by an increase in expression of inflammatory markers on the surface of infiltrated DCs, is often observed [18] . Activation of AECs by pathogens also induces various chemokines and cytokines, such as interferon (IFN)-a and IFN-k, which are essential for priming of immune cells [15, 19] .The end-point of the AEC-modulated DC functional phenotype is a significant increase in antigen uptake, processing and chemotactic that is followed by T cell activation.
Most studies regarding the effect of AECs on DCs have focused upon either the tolerance induction or Th2 immunity [8, 20, 21] . Moreover, the studies have determined the effect of activated AECs on DCs. Particularly in humans, there is a scarcity of information regarding the interaction between AECs and DCs and its effect on immunity at homeostasis. How the DCs respond to infections in the presence of tolerogenic signals provided by the AECs remains to be fully elucidated. To investigate this, we examined the effect of AECs on the myeloid DC (mDC) functions in humans utilizing the recently developed DC-AEC co-culture model.
Materials and methods

Blood donors
Peripheral blood samples were obtained from healthy young volunteers. This study was approved by the Institutional Review Board of the University of California (Irvine, CA, USA).
Primary bronchial epithelial cells (PBECs)
PBECs [Air-liquid interphase (ALI)-tested] from three normal, healthy young individuals were obtained from Lonza Inc. (Basel, Switzerland). The PBECs were differentiated at the ALI on Transwell plates in the medium provided by the manufacturer (Lonza), as per their instructions. Briefly, 5 3 10 4 PBECs per insert were seeded into the rat tail collagen (BD Biosciences, San Jose, CA, USA)-coated apical chamber of a 24-well Transwell plate in 100 ml B-ALI TM growth medium; 500 ml of B-ALI TM growth medium was added to the basal chamber of wells containing the inserts. On day 3 after seeding, once the monolayer of PBEC was confluent, media were removed from the apical chamber and 500 ll of B-ALI differentiation media was added to the bottom chamber. The media in the bottom chamber were changed every alternate day. Approximately 28 days post-differentiation, PBECs were tested for the presence of cilia by staining for beta-tubulin (data not shown). Mucus secretion was also observed by the cells. At this time these cells also displayed high level transepithelial electrical resistance (TEER) and resistance to dextran fluorescein isothiocyanate (FITC) migration measured as described earlier [10] .
Isolation and culture of human mDCs with PBECs
Myeloid DCs (mDCs) were purified from the peripheral blood mononuclear cells (PBMCs) of young subjects by negative selection using a myeloid DC purification kit (Miltenyi Biotech, San Diego, CA, USA). ) from five different donors were added to the bottom chamber (five different) for 24 h. Subsequently the mDCs were collected for genomics and other studies. For genomic studies, mDCs were cultured with PBECs from one donor. For functional studies, mDCs were cultured with PBECs from two other donors different from the one used for genomic studies to confirm the results.
Staining and stimulation of mDCs mDCs cultured with and without AECs were stained with specific antibodies against Toll-like receptor (TLR)-2, TLR-4 (surface), TLR-8 and Nod-like receptor (NLR)P3 (intracellular) from R&D Systems (Minneapolis, MN, USA). Acquisition was performed on a FACS Calibur and analysis using Flow Jo (TreeStar, Inc., Ashland, OR, USA). Supernatants collected were assayed for chemokines CCL5, CCL17, CCL24, CXCL5 and CXCL13, as well as S100A8, using a multiplex kit from R&D Systems.
mDCs cultured with and without AECs were stimulated with Klebsiella pneumoniae lipopolysaccharide (LPS) (Sigma-Aldrich, St Louis, MO, USA) at 100 ng/ml for 24 h. Supernatants collected were assayed for cytokines tumour necrosis factor (TNF)-a, IL-6, IL-1b and IL-10 by specific ELISAs, as per the manufacturer's protocol (BD Biosciences, San Jose, CA, USA).
For the subset experiments, enriched DCs were stained with Lineage, CD1c, CD141 and CD123. mDCs were sorted into CD1c and CD141 1 subsets using FACSAria at the flow cytometry core at UCI. Both the subsets were stimulated with LPS as described above.
Mice DC staining
Lung and spleen were harvested from normal C57BL6 mice. The tissues were digested in collagenase to prepare a single-cell suspension. The cells were stained with CD11c, CD103, TLR-2, TLR-4 and NLRP3 (Fisher Scientific, Fremont, CA, USA). Gated DCs in both tissues were analysed for the expression of TLR-2, TLR-4 and NLRP3. Gating strategy is included in the Supporting information, Fig. S4 .
Gene expression
Gene expression of mDC was determined using the immune cancer-profiling panel from NanoString (Seattle, WA, USA). Samples were subjected to NanoString nCounter TM analysis by the University of California genomics facility. The detailed protocol for mRNA transcript quantification analysis, including sample preparation, hybridization, detection and scanning, followed the manufacturer's recommendations, and are available at http://www.nanostring.com/ uploads/Manual_Gene_Expression_Assay.pdf/ under http:// www.nanostring.com/applications/subpage.asp?id5343. We used 100 ng of total RNA isolated from mDC, as suggested by the manufacturer.
Statistical analyses
Absolute mRNA quantification values obtained by the NanoString Multi Experiment Viewer (MEV) [22] , which is one member of a suite of microarray data management and analysis applications developed originally at the Institute of Genomics Research (TIGR), were used to analyse the data. The gene expression values obtained from NanoString were imported into the program. Samples were assigned to either stimulated or non-stimulated groups and genes that had significantly different mean log2 expression ratios between the two groups were assigned to one cluster (significant), while the genes that were not significantly different between the two groups were assigned to another cluster (non-significant). One-way analysis of variance (ANOVA) was performed using a parametric test and variances not assumed equal (Welch's t-test) was used to calculate the raw P-value and false discovery rate (FDR)-adjusted Pvalue of < 0Á05, which implies that 5% of significant tests will result in false positives.
Pathway analysis in Strand next-generation sequencing (NGS) was utilized to understand the role of differentially expressed genes and their biological functions in stimulated versus non-stimulated cells. NanoString probe identifiers and fold-values were imported into the Strand NGS program, which compares the imported gene list with pathways in a pathway collection (curated pathways such as Wiki Pathways, BioCyc and literature-derived pathways) and identifies common genes and computes the statistical significance of the pathways. The resulting pathway list was filtered on the basis of the number of common genes (n > 4 genes) and P < 0Á05.
Statistical analysis for cell culture experiments was performed using GraphPad Prism (GraphPad Inc., San Diego, CA, USA). Differences between unstimulated and stimulated conditions were tested using the paired t-test. A Pvalue of < 0Á05 was considered statistically significant.
Results
AECs alter the expression of chemokine and S100 protein genes in mDCs Studies focused on the tolerogenic effects of individual factors secreted by AECs, such as retinoic acid and TGF-b, on DCs at homeostasis are well documented [8, 14, 20, 23] . However, there is a scarcity of information regarding the effect of AEC soluble signals on DCs and their effect on immunity, particularly in humans. We investigated the effect of AECs on mDC gene expression changes using the Transwell co-culture system. mDCs were chosen because all DCs originate from the bone marrow, from where they populate different areas of the body. The microenvironment in which the mDCs reside further influences and modifies the DC functions. The model uses PBECs which are cultured at the ALI to induce the differentiation PBECs to generate a pseudostratified epithelium that recapitulates the physiology of the airway epithelium. The B-ALIcertified PBECs from healthy subjects are obtained from Lonza Inc., and differentiation to ALI is performed following Lonza's protocol. To investigate the effect of AECs in the form of PBECs on mDCs, the PBECS were cultured at ALI until differentiation is achieved. mDCs purified from the blood were then added to the basal side of the monolayer to model the airways [24, 25] . An aliquot of the mDCs was also cultured without AECs, but with the media. 24 h later mDCs were collected and RNA was extracted. The viability was comparable between mDCs cultured with and without AECs (Supporting information, Fig. S2 ). Gene expression changes were determined using the Pan Cancer Immune profiling panel of 770 genes from NanoString Technologies. mDCs from five different subjects were used for the study. Analysis revealed that a total of 142 of 770 genes in mDCs displayed a significant change (P < 0Á05) in expression after culture with AECs (Supporting information, Table S1 ). Among the various genes displaying changes were a number of chemokine and chemokine receptor genes (Table 1) . Chemokines represent a family of low molecular weight chemotactic proteins which may be either expressed constitutively or inducible on activation. Chemokine receptors can sense chemokines and allow cells to migrate towards the chemokine gradient. Genes for CCL17, CCND3, CCR2 and CXCL5 were up-regulated, while CCL5, CXCL13, CCL24, CXCL16 and CXCR3 were down-regulated.
The genes for S100 A8 (MRP8, Calgranulin A) and S100A12 (Calgranulin C) proteins were also up-regulated significantly in mDCs after culture with AECs (Table 1) . S100 proteins can be involved in cellular homeostasis or serve as proinflammatory danger or stress signals.
Next, we investigated whether the changes observed at the level of gene expression are also transcribed to proteins. Few of the chemokines and S100 genes were confirmed at the protein level. The secretion of chemokines CCL5, CCL17, CCL24, CXCL5 and CXCL13, as well as S100A8, by mDCs after culture with AECs was determined by multiplex bead assay. As shown in Fig. 1 , the protein data correlated with the gene expression data for all the chemokines as well as S100A8. CCL17, CXCL5 and S100A8 levels were higher in mDCs cultured with AECs while CCL5, CCL24 and CXCL13 levels were decreased. These chemokines were not detectable in PBEC supernatants without DCs.
Altogether, these data suggest that AECs affect the expression of chemokines and S100 in mDCs at the level of both genes and protein.
AECs enhance the expression of pathogen recognition and response genes in mDCs Investigation suggested that pathogen recognition receptor (PRR) pathways, such as the TLR and Nod-like receptor pathways, were affected significantly (P < 0Á05) in mDCs after culture with AECs ( Table 2 ). The expression of genes for TLR-2, TLR-4 and TLR-8, as well as the downstream signalling molecules, myeloid differentiation primary response gene 88 (MyD88) and interleukin (IL)-1 receptorassociated kinase 1 (IRAK-1), were up-regulated significantly (P < 0Á05) (Fig. 2, Table 3 ) in mDC cultured with AECs compared to mDC without AECs. Furthermore, the expression of negative regulators of the TLR pathway, such as triggering receptor expressed on myeloid cells 2 (TREM-2) and NLR family CARD domain containing 5 (NLRC5), was also significantly (P < 0Á05) down-regulated (Fig. 2 , Table 1 . Chemokine and S100 gene changes in myeloid dendritic cells (mDCs) after culture with airway epithelial cells (AECs) Fold change   CCL17  8Á88E-05  13Á03  CCL24  0Á0098  0Á37  CCL5  0Á0123  0Á73  CCND3  0Á0062  2Á24  CCR2  0Á0092  5Á66  CXCL13  0Á0003  0Á04  CXCL16  0Á0187  0Á61  CXCL5  0Á0023  3Á29  CXCR3  0Á0128  0Á62  S100A12 0Á0081 1Á27 S100A8 0Á0099 1Á32 Fig. 1 . Airway epithelial cells (AECs) alter the expression of chemokine and S100 protein genes in myeloid dendritic cells (mDCs). Bar graphs depict the level of chemokines and S100 A8 proteins secreted by mDC 6 primary bronchial epithelial cells (PBECs) as determined by multiplexing. Data are mean 6 standard error (s.e.) of five different subjects. Table 3 ). A significant increase (P < 0Á05) in the inflammasome-associated molecules NLRP3, caspase-1 and IL-1b was observed (Fig. 2, Table 3 ), and the expression of NLR2 was also up-regulated (Fig. 2, Table 2 ). Altogether, these data suggest that AECs enhance the expression of pathogen recognition and response genes in mDCs.
Genes
P-value
Confirmation of the expression and response of PRRs in mDC by AECs at the protein level
Next, we determined whether the gene expression results are also visible at the level of proteins and whether the increased expression results in enhanced function of these genes. mDCs cultured with and without AECs were stained for the expression of certain PRRs. As is evident from Fig.  3a , the expression of TLR-2, TLR-4, TLR-8 and NLRP3 was up-regulated significantly (P < 0Á05) in mDCs cultured with AECs compared to mDCs cultured without AECs. These data confirm that the gene expression changes observed are transcribed into proteins. We next investigated if the enhanced expression of TLRs also increases the inflammatory response of mDCs to their ligands. Stimulation of mDCs cultured with and without AECs with LPS resulted in secretion of significant levels of TNF-a, IL-6, IL-1b and IL-10 compared to unstimulated mDCs (Fig. 3b) . However, the secretion of TNF-a, IL-6 and IL-1b was significantly higher (P < 0Á05) in mDCs cultured with AECs compared to mDCs cultured without AECs, suggesting that the increased expression of TLR-4 results in enhanced secretion of inflammatory cytokines. Enhanced secretion of IL-1b is in keeping with increased expression of the inflammasome genes. The IL-10 secretion was comparable between the two groups. There was no significant level of secreted cytokines detected in epithelial cells cultured without mDCs. These data confirm that AECs enhance the expression of PRRs on mDCs and that these receptors are functional. mDCs in circulation are divided into two major subsets: CD1c and CD141. Between these two subsets, the CD1c subset constitutes the major population of mDCs in PBMCs (approximately 1%), while CD141 subset constitutes only 0Á1% of the mDCs, as it resides primarily in tissues. We therefore performed additional experiments to determine whether the observed enhanced PRR response is restricted to a particular mDC subset. As is evident from Fig. 3, CD1c DCs displayed similar enhanced responses to LPS to those observed by total mDC populations (Fig. 3c) . Following stimulation with LPS, significant levels of secreted TNF-a, IL-1b and IL-6 were detected in AEC-exposed CD1c mDCs compared to unexposed controls (P < 0Á05). However, the level of secreted IL-0 was not significantly different between the two populations (P > 0Á05).
There were no detectable levels of secreted TNF-a, IL-1b and IL-10 by CD141
1 DCs (data not shown). However, we observed an increased secretion of IL-6 from CD141 1 DCs when cultured with AECs, which was not increased significantly following stimulation with LPS (Supporting information, Fig. S3 ). Altogether, these results suggest that AECs enhance the PRR response primarily in the CD1c subset of mDCs.
DCs from the lung display enhanced expression of PRRs compared to DCs from the spleen in mice
The observations obtained in vitro using human DC and AECs were further confirmed in vivo in mice. Lung and Pathway analysis of genes with P-value <0Á05 was performed using the strand NGS software. The statistical significance of each pathway has been computed by comparing our gene list with the pathways in a pathway collection. Then we filtered pathway list based on the common genes (> 4 genes) P-value significance < 0Á0001. Only the pathways showing five or more gene changes are displayed. MyD88 5 myeloid differentiation primary response gene 88; IRAK-1 5 interleukin-1 receptor-associated kinase 1; NLR 5 Nod-like receptor family; NLR 5 Nod-like receptor; MHC 5 major histocompatibility complex; TCR 5 Toll-like receptor; GPCR 5 G-protein-coupled receptors; MAPK 5mitogen-activated protein kinase; DAP12 5 DNAX activation protein of 12kDa; TSLP 5 thymic stromal lymphopoietin; IL 5 interleukin; AGE-RAGE 5 advanced glycation end products-receptor for AGE; BDNF 5 brain-derived neurotrophic factor. TLR-2  0Á046212  2Á585  TLR-4  0Á025788  1Á97  TLR-8  0Á024634  1Á985  MYD88  0Á019107  1Á471  IRAK-1  0Á018075  1Á377  TREM-2  0Á017637  0Á749  NLRC5  0Á005133  0Á604  NLRP3  0Á000152  2Á121  CASP-1  0Á022802  2Á639  IL-1B  0Á042771  3Á876  Nod2 0Á003346 1Á978
MyD88 5 myeloid differentiation primary response gene 88; IRAK-1 5 interleukin-1 receptor-associated kinase 1; TREM-2 5 triggering receptor expressed on myeloid cells 2; NLRP3 5 Nod-like receptor P3; CASP-1 5 caspase 1; IL 5 interleukin. spleen cells from unimmunized mice were stained for DC and PRR markers. Lungs were chosen as our human mDC AEC culture represents the respiratory DCs, while spleen DCs were representative of a non-mucosal tissue. As is clear from Fig. 4 , the expression of TLR-4, TLR-2 and NLRP3 was increased significantly (P < 0Á05) in the CD11c, CD103 DCs from lung compared to DCs from spleen. These data confirm our in vitro observations.
Other significant changes in gene expression observed in DCs cultured with AECs
One of the major functions of DCs is antigen presentation. On examining the changes in antigen-presenting genes, it was observed that the expression of class II major histocompatibility complex (MHC) gene major histocompatibility complex, class II, DM beta (HLA-DMB) and lysosomal-associated membrane protein 1 (LAMP-1), as well as CD80, were up-regulated significantly (Supporting information, Table S1 ). Furthermore, culture of mDCs with AECs also led to significant up-regulation (35-fold) of the expression of CD1d, which primes T cells and natural killer (NK) T cells that recognize lipids, glycolipids or lipopeptide antigens [26] .
Discussion
Multiple gaps exist in the understanding of the basic immune mechanisms responsible for the induction of mucosal immunity in the airways. Emerging evidence suggests that AECs play a major role in regulating immunity and tolerance in the airways [5] . In this study we have investigated the gene expression changes in mDCs brought about by AECs with a view to understanding the role of AECs in priming immunity in DCs. This is especially important, as the mucosal environment including AECs is involved in suppressing the function of DCs to prevent a response to harmless inhaled antigens. Numerous studies have outlined the effect of thymic stromal lymphopoietin (TSLP), IL-33 and IL-25 [21, 27] secreted by activated AECs on mDCs. However, it is not clear if the AECs also provide signals at homeostasis which allow DCs to overcome this suppression and respond to threats when required. Our results indicate that soluble factors from PBECs enhance the immunogenicity of DCs by altering the secretion of various chemokines (Fig. 1, Table 1 ) and upregulating the expression of TLRs and NLRs and their downstream signalling components (Tables 2 and 3, Fig. 2) . Enhanced expression and function of TLR-2, TLR-4, TLR-8 and NLRP3 in mDCs cultured with PBECs (Figs 2 and 3) was also observed. Furthermore, the increased expression of these receptors on DCs was also observed in vivo in mice (Fig. 4) , confirming the results with the culture of mDCs with PBECs. Thus, the co-culture system of human mDC and PBECs serves as a model representing the mDCs in the lung. Previous gene expression studies performed comparing banked bronchial epithelial cells and brushed cells [28] also suggest that ALI cells provide a good representation of the in-vivo airway epithelial transcriptome. Mathis and colleagues [29] showed that the responses of these tissue models to cigarette smoke were similar to the differences observed between bronchial epithelial cells obtained from smokers and cells obtained from non-smokers.
Further studies revealed that it was primarily the CD1c subset of mDCs which displayed the enhanced response to TLR ligand, LPS (Fig. 3c ). This suggests a scenario whereby AECs act on CD1c mDC subset to enhance immunogenicity and fight infections. In contrast, they induce tolerance in CD141
1 mDCs to prevent response to inhaled antigens.
Studies from the literature point to the CD141 1 mDCs in the tissues to be equivalent to CD103 mDCs of mouse [8, 13, 14] , which are involved in inducing tolerance in mucosal tissues. However, further experiments are required to confirm this hypothesis.
Only one other previous study by Rate et al. [30, 31] has examined the effect of AECs on human DCs at homeostasis by microarray utilizing the in-vitro co-culture model. The study used the AEC cell line, 16HBE14o 2 , as a representative of AECs. Instead of mDCs from circulation, monocytes which were differentiated for 5 days in the presence of AECs were used. Monocytes have been reported to differentiate into DCs in the lung under inflammatory conditions. Therefore, this study is more representative of inflammatory DCs than DCs present in normal homeostatic conditions. That being said, many of the changes reported in this study were similar to what we observed in the present paper, although there were also marked differences. Rate et al. observed enhanced expression of pathogen recognition receptors (PRRs), including TLR-3 and TLR-4 [30] on DCs after exposure to AECs, while in our studies the expression of TLR-2, 24, 28, Nod-1, 22 and NLRP3 as well as associated downstream signalling pathways were up-regulated in mDCs cultured with AECs (Fig.  2, Table 2 ). We did not observe a change in TLR-3 expression on mDCs after AEC co-culture. Altogether, mDCs depict enhanced expression of multiple PRRs compared to monocyte-derived DCs.
We also observed significant changes in the secretion of various chemokines (Fig. 1, Table 1 ). The secretion of CCL17 by mDCs was increased substantially after co-culture with AECs. CCL17 has been reported to promote recruitment of T helper type 2 (Th2) cells expressing CCR4 [32] . However, emerging evidence supports the notion that CCL17 can attract regulatory T cells (T regs ) [33] . Furthermore, CCL17 sensitizes DCs for CCR7 and CXCR4 dependent migration to LN-associated homeostatic chemokines [34] . In addition to CCL17, secretion of CXCL5 was also enhanced in mDCs after co-culture with AECs. CXCL5 has been reported to suppress the ability of DCs to secrete the Th1-promoting cytokine IL-12p70 in response to LPS [35] , but induces neutrophil recruitment. In contrast to CCL17 and CXCL5, secretion of CCL24, CCL5 and CXCL13 was down-regulated in mDCs cultured with AECs (Fig. 1) . Blockade of CCL24 in lung DCs has been reported to prevent the airway eosinophilia and Th2 lung inflammation in mice given house dust mite [36] . CCL5/regulated on activation, normal T cell expressed and secreted (RANTES) is an inflammatory chemokine which attracts T cells and DCs during infections while CXCL13 is a potent B lymphocyte chemoattractant [37] . Gene expressions of CXCL16 and CXCR3, which promotes NK T and Th1 immunity, are down-regulated, while CCR2 expression, which promotes Th1, immunity is up-regulated substantially on mDCs cultured with AECs. Furthermore, the genes for IL-17RB, the receptor for IL-25 [38] and TNF superfamily member 4 (TNFSF4) (OX40L) [39] , promoting allergic inflammation, are also down-regulated (Supporting information, Table S1 ). Taken together, these data suggest that chemokines secreted by AECs promote a balance of Th1/Th2 immunity and prime the influx of neutrophils and NK cells to the lung. These results are in contrast to the observations of Rate et al. [31] , where the expression of chemokines such as CCL5 and CCL24, etc. were up-regulated and promoted mainly a Th1-type response. The type of chemokines secreted were also different, suggesting that AECs have a differential effect of inflammatory monocyte derived DCs versus the circulatory myeloid DCs.
The expression of genes for S100A8 and S100A12 was also increased on DCs cultured with AECs (Table 1 , Fig. 1 ). These S100 proteins are part of the family of calgranulins [40] . S100A8 can exist as a homodimer, or it heterodimerizes with S100A9 to form calprotectin, which functions as an anti-microbial protein. In contrast, S100A12 (EN-RAGE) exists as a homodimer and functions as a receptor for advanced glycation end products (RAGE). RAGE is expressed at high levels on AECs, where it is involved in immune surveillance against self and foreign antigens [40] .
In addition to PRRs and chemokines, AECs also induced changes in the expression of various antigen-presenting molecules on DCs. The expression of MHC-II antigenpresenting molecules, HLA-DMB and CD80, as well as lipid antigen-presenting molecule CD1d, were upregulated, indicating a primed state of DCs to respond to infections (Supporting information, Table S1 ). The expression of Fcg and FcE receptor genes was also up-regulated (Supporting information, Table S1 ). These data complement previous observations, wherein AEC conditioning of DC, in a contact-dependent fashion during differentiation of the latter, up-regulated a variety of surface markers, including HLA-DR, CD40 and CD80 [30] as well as the Fcg receptor; however, no difference in CD1d or FcE receptor expression was reported [31] . The AECs thus seem to prime DCs for MHC-II and glycolipid antigens.
Our studies suggest that AECs modulate DC immunity not only after activation but also during homeostasis. Alterations in the functions of AECs at homeostasis may therefore modulate the response of DCs to infections. A previous study from our laboratory has demonstrated that inflammatory DCs from elderly individuals can modulate the function of AECs at homeostasis [10] . Taken together, these studies suggest that interaction of AECs and DCs at homeostasis plays a major role in maintaining immunity and tolerance in the airways. This concept is displayed in Fig. 5 .
One caveat of our study is that it only examines the effect of AECs soluble factors on DC function. AECs may also be providing contact-dependent signals to DCs, which is an area of further investigation.
In summary, we demonstrate for the first time that AECs regulate the immune response of mDCs at homeostasis by enhancing their immunogenicity. AECs alter chemokine secretion by mDCs which allow priming of neutrophils, NK cells and a balance of Th1/Th2 responses. There is increased production of S100 proteins, which have anti-microbial and alarmin activities. The capacity of DCs to induce MHC-II-and CD1d-restricted responses also increases. The AECs secrete soluble factors which upregulate the expression of TLRs, NLRs and their downstream effectors both at the level of genes and protein.
There is increased LPS-induced inflammatory cytokine secretion by DCs cultured with AECs, particularly in the CD1c mDC subset. Furthermore, similar to humans, lung DCs from mice also display increased expression of TLRs and NLRs compared to peripheral spleen DCs. The enhanced pathogen sensing is most probably a mechanism to compensate for the tolerance which dampens the immune response. 
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Additional Supporting information may be found in the online version of this article at the publisher's web-site: Table S1 . List of significant gene changes in myeloid dendritic cells (mDCs) after culture with airway epithelial cells (AECs) Fig. S1 . Primary bronchial epithelial cells (PBECs) were grown on Transwell membranes and differentiated at air liquid interphase (ALI). After 28 days the membranes were fixed and cryosectioned (20 lm). Subsequently, staining was performed with beta-tubulin antibody (green-Dylight 488, Thermo Fisher) to detect cilia. 4',6-diamidino-2-phenylindole (DAPI) (blue) was used to stain cell nuclei. 
